1 / 1

Overcoming Treatment Limitations for Epstein-Barr Virus-Associated Malignancies

The management of Epstein-Barr virus (EBV) associated malignancies presents several challenges, including the virus's ability to evade immune responses and the limited efficacy of existing treatments. This paper by Khanna et al. (2005) explores the limitations faced in treating these malignancies and highlights emerging immunotherapeutic strategies that could enhance clinical outcomes. By understanding the unique biology of EBV-related cancers, researchers aim to develop targeted therapies that could improve patient prognosis and provide hope for more effective treatments.

jane-mcgee
Télécharger la présentation

Overcoming Treatment Limitations for Epstein-Barr Virus-Associated Malignancies

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Table 2 Limitations in the treatment of Epstein-Barr virus-associated malignancies and potential strategies to overcome these limitations Khanna R et al. (2005) Technology Insight: applications of emerging immunotherapeutic strategies for Epstein-Barr virus-associated malignancies.Nat Clin Pract Oncol 2: 138–149 10.1038/ncponc0107

More Related